21 December 2023

~1 minutes read

Galway MedTech company receive €1.5 million for device for late-stage cancer patients

Share story:
Galway MedTech company receive €1.5 million for device for late-stage cancer patients

A Galway Medtech company has received one point five million euro in a seeded funding round for a device for late-stage cancer patients.

SymPhysis Medical produce a device called ‘rel-eaze’ which deals with fluid in the chest and helps late-stage cancer patients to manage the condition independently.

The money will also support team growth, new jobs in research and development, product engineering and commericalisation and product engineering.

The company will seek an additional four point five million to support the continued development of the device early next year.

Share story:

UG SU President cites lack of mental health support as major reason drop-out rates are up

University of Galway’s Students’ Union President is citing a lack of mental health support as one of main reasons for an increase in drop out ...

HSE under fire as report into newborn head injuries at UHG will not be made public

There are no plans to publish the review of the 9 cases of head injuries to newborn babies at UHG in 2022. Experts have examined cases where babies were d...

Lidl in Gort set to be demolished and rebuilt

Lidl in Gort is set to be demolished – and replaced with a brand new and improved building. It’s after county planners gave the green light fo...

Gort and Athenry chosen for new Town Centre First plan

Gort and Athenry have been chosen for Galway for the Government’s new Town Centre First plan. The plans represent the vision of local people for the...